SPINI, ANDREA
SPINI, ANDREA
Dipartimento di Scienze della Vita
Chapter 2. Antiangiogenic drugs: Chemosensitizers for combination cancer therapy
2022-01-01 Donnini, Sandra; Filippelli, Arianna; Ciccone, Valerio; Spini, Andrea; Ristori, Emma; Ziche, Marina; Morbidelli, Lucia
Development and validation of a case-finding algorithm for the identification of non-small cell lung cancers in a region-wide Italian pathology registry
2022-01-01 Spini, Andrea; Rosellini, Pietro; Bellan, Cristiana; Furiesi, Folco; Giorgi, Silvano; Donnini, Sandra; Gini, Rosa; Ziche, Marina; Salvo, Francesco; Roberto, Giuseppe
Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review
2019-01-01 Spini, A.; Roberto, G.; Gini, R.; Bartolini, C.; Bazzani, L.; Donnini, S.; Crispino, S.; Ziche, M.
First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: a real-life setting study with gender prospective
2021-01-01 Spini, A.; Gini, R.; Rosellini, P.; Singier, A.; Bellan, C.; Pascucci, A.; Leoncini, L.; Mathieu, C.; Martellucci, I.; Furiesi, F.; Giorgi, S.; Donnini, S.; Roberto, G.; Ziche, M.; Salvo, F.
Linking regional administrative data with an hospital pathology registry in Italy to describe first-line pharmacotherapy of non-resectable non-small cell lung cancer in 2009-2017
2020-01-01 Spini, A; Roberto, G; Bellan, C; Pascucci, A; Rosellini, P; Caldarella, A; Barchielli, A; Donnini, S; Furiesi, F; Leoncini, L; Giorgi, S; Bartolini, C; Zappa, M; Ziche, M; Salvo, F; Gini, R
Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data
2020-01-01 Roberto, G.; Spini, A.; Bartolini, C.; Moscatelli, V.; Barchielli, A.; Paoletti, D.; Giorgi, S.; Fabbri, A.; Bocchia, M.; Donnini, S.; Gini, R.; Ziche, M.
Repurposing of drugs for triple negative breast cancer: an overview
2020-01-01 Spini, A; Donnini, S; Pantziarka, P; Crispino, S; Ziche, M
Risk of intraocular pressure increase with intravitreal injections of Vascular Endothelial Growth Factor Inhibitors: a cohort study
2023-01-01 Spini, Andrea; Giometto, Sabrina; Donnini, Sandra; Posarelli, Matteo; Dotta, Francesco; Ziche, Marina; Tosi, Gian Marco; Girardi, Anna; Lucenteforte, Ersilia; Gini, Rosa; Etminan, Mahyar; Virgili, Gianni
Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis
2022-01-01 Spini, Andrea; Ciccone, Valerio; Rosellini, Pietro; Ziche, Marina; Lucenteforte, Ersilia; Salvo, Francesco; Donnini, Sandra
Scoping Review on Platelets and Tumor Angiogenesis: Do We Need More Evidence or Better Analysis?
2022-01-01 Filippelli, Arianna; Del Gaudio, Cinzia; Simonis, Vittoria; Ciccone, Valerio; Spini, Andrea; Donnini, Sandra
Sex differences in the utilization of drugs for COVID-19 treatment among elderly residents in a sample of Italian nursing homes
2022-01-01 Spini, Andrea; Crescioli, Giada; Donnini, Sandra; Ziche, Marina; Collini, Francesca; Gemmi, Fabrizio; Virgili, Gianni; Vannacci, Alfredo; Lucenteforte, Ersilia; Gini, Rosa; Lombardi, Niccolò; Roberto, Giuseppe
Validity of Italian administrative healthcare data in describing the real-world utilization of infusive antineoplastic drugs: the study case of rituximab use in patients treated at the University Hospital of Siena for onco-haematological indications
2023-01-01 Bartolini, C.; Roberto, G.; Girardi, A.; Moscatelli, V.; Spini, A.; Barchielli, A.; Bocchia, M.; Fabbri, A.; Donnini, S.; Ziche, M.; Monti, M. C.; Gini, R.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Chapter 2. Antiangiogenic drugs: Chemosensitizers for combination cancer therapy | 1-gen-2022 | Donnini, Sandra; Filippelli, Arianna; Ciccone, Valerio; Spini, Andrea; Ristori, Emma; Ziche, Marina; Morbidelli, Lucia | - | |
| Development and validation of a case-finding algorithm for the identification of non-small cell lung cancers in a region-wide Italian pathology registry | 1-gen-2022 | Spini, Andrea; Rosellini, Pietro; Bellan, Cristiana; Furiesi, Folco; Giorgi, Silvano; Donnini, Sandra; Gini, Rosa; Ziche, Marina; Salvo, Francesco; Roberto, Giuseppe | - | |
| Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review | 1-gen-2019 | Spini, A.; Roberto, G.; Gini, R.; Bartolini, C.; Bazzani, L.; Donnini, S.; Crispino, S.; Ziche, M. | - | |
| First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: a real-life setting study with gender prospective | 1-gen-2021 | Spini, A.; Gini, R.; Rosellini, P.; Singier, A.; Bellan, C.; Pascucci, A.; Leoncini, L.; Mathieu, C.; Martellucci, I.; Furiesi, F.; Giorgi, S.; Donnini, S.; Roberto, G.; Ziche, M.; Salvo, F. | - | |
| Linking regional administrative data with an hospital pathology registry in Italy to describe first-line pharmacotherapy of non-resectable non-small cell lung cancer in 2009-2017 | 1-gen-2020 | Spini, A; Roberto, G; Bellan, C; Pascucci, A; Rosellini, P; Caldarella, A; Barchielli, A; Donnini, S; Furiesi, F; Leoncini, L; Giorgi, S; Bartolini, C; Zappa, M; Ziche, M; Salvo, F; Gini, R | - | |
| Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data | 1-gen-2020 | Roberto, G.; Spini, A.; Bartolini, C.; Moscatelli, V.; Barchielli, A.; Paoletti, D.; Giorgi, S.; Fabbri, A.; Bocchia, M.; Donnini, S.; Gini, R.; Ziche, M. | - | |
| Repurposing of drugs for triple negative breast cancer: an overview | 1-gen-2020 | Spini, A; Donnini, S; Pantziarka, P; Crispino, S; Ziche, M | - | |
| Risk of intraocular pressure increase with intravitreal injections of Vascular Endothelial Growth Factor Inhibitors: a cohort study | 1-gen-2023 | Spini, Andrea; Giometto, Sabrina; Donnini, Sandra; Posarelli, Matteo; Dotta, Francesco; Ziche, Marina; Tosi, Gian Marco; Girardi, Anna; Lucenteforte, Ersilia; Gini, Rosa; Etminan, Mahyar; Virgili, Gianni | - | |
| Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis | 1-gen-2022 | Spini, Andrea; Ciccone, Valerio; Rosellini, Pietro; Ziche, Marina; Lucenteforte, Ersilia; Salvo, Francesco; Donnini, Sandra | - | |
| Scoping Review on Platelets and Tumor Angiogenesis: Do We Need More Evidence or Better Analysis? | 1-gen-2022 | Filippelli, Arianna; Del Gaudio, Cinzia; Simonis, Vittoria; Ciccone, Valerio; Spini, Andrea; Donnini, Sandra | - | |
| Sex differences in the utilization of drugs for COVID-19 treatment among elderly residents in a sample of Italian nursing homes | 1-gen-2022 | Spini, Andrea; Crescioli, Giada; Donnini, Sandra; Ziche, Marina; Collini, Francesca; Gemmi, Fabrizio; Virgili, Gianni; Vannacci, Alfredo; Lucenteforte, Ersilia; Gini, Rosa; Lombardi, Niccolò; Roberto, Giuseppe | - | |
| Validity of Italian administrative healthcare data in describing the real-world utilization of infusive antineoplastic drugs: the study case of rituximab use in patients treated at the University Hospital of Siena for onco-haematological indications | 1-gen-2023 | Bartolini, C.; Roberto, G.; Girardi, A.; Moscatelli, V.; Spini, A.; Barchielli, A.; Bocchia, M.; Fabbri, A.; Donnini, S.; Ziche, M.; Monti, M. C.; Gini, R. | - |